+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Live Cell Imaging Market (2022-2027) by Product & Service, Application, Technology, End User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 179 Pages
  • April 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5601824
UP TO OFF until Dec 31st 2023
The Global Live Cell Imaging Market is estimated to be USD 2.07 Bn in 2022 and is projected to reach USD 2.99 Bn by 2027, growing at a CAGR of 7.6%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Live Cell Imaging Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Live Cell Imaging Market is segmented based on Product & Service, Application, Technology, End User and Geography.
  • By Product & Service, the market is classified into Instruments, Consumables, Software, and Services.
  • By Application, the market is classified into Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery.
  • By Technology, the market is classified into Time-Lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-Content Screening (HCS), and Other.
  • By End User, the market is classified into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Biotek Instruments, Becton, Dickinson & Company, Bruker, Carl Zeiss, Cytosmart, Danaher, GE Healthcare, Sony Biotechnology, Thermo Fisher Scientific, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Live Cell Imaging Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The report analyses the Global Live Cell Imaging Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Live Cell Imaging Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Live Cell Imaging Market

What is the estimated value of the Global Live Cell Imaging Market?

The Global Live Cell Imaging Market was estimated to be valued at $2.07 Billion in 2022.

What is the growth rate of the Global Live Cell Imaging Market?

The growth rate of the Global Live Cell Imaging Market is 7.6%, with an estimated value of $2.99 Billion by 2027.

What is the forecasted size of the Global Live Cell Imaging Market?

The Global Live Cell Imaging Market is estimated to be worth $2.99 Billion by 2027.

Who are the key companies in the Global Live Cell Imaging Market?

Key companies in the Global Live Cell Imaging Market include Biotek Instruments, Becton, Dickinson & Company, Bruker, Carl Zeiss, Cytosmart, Danaher, Etaluma, GE Healthcare, Keyence and Logos Biosystems.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Adoption of High-Content Screening Techniques in Drug Discovery
4.1.2 Growing Incidence of Cancer
4.1.3 Increasing Availability of Research Funds
4.1.4 Increase in Government Funding in Regenerative Medicine Research
4.2 Restraints
4.2.1 High Cost of High-Content Screening Systems
4.3 Opportunities
4.3.1 Applications of HCS in Personalized Medicine
4.4 Challenges
4.4.1 Maintaining Cell Viability and the Cellular Environment in Cell Cultures
4.4.2 Lack of Skilled Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Live Cell Imaging Market, By Product & Service
6.1 Introduction
6.2 Instruments
6.2.1 Microscopes
6.2.2 Standalone Systems
6.2.3 Cell Analyzers
6.2.4 Accessories
6.3 Consumables
6.3.1 Reagents
6.3.2 Assay Kits
6.3.3 Media
6.4 Software
6.5 Services
7 Global Live Cell Imaging Market, By Application
7.1 Introduction
7.2 Cell Biology
7.3 Stem Cells
7.4 Developmental Biology
7.5 Drug Discovery
8 Global Live Cell Imaging Market, By Technology
8.1 Introduction
8.2 Time-Lapse Microscopy
8.3 Fluorescence Resonance Energy Transfer (FRET)
8.4 Fluorescence Recovery After Photobleaching (FRAP)
8.5 High-Content Screening (HCS)
8.6 Other
9 Global Live Cell Imaging Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Contract Research Organizations
10 Americas’ Live Cell Imaging Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe’s Live Cell Imaging Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe
12 Middle East and Africa’s Live Cell Imaging Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA
13 APAC’s Live Cell Imaging Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements
15 Company Profiles
15.1 Biotek Instruments
15.2 Becton, Dickinson & Company
15.3 Bruker
15.4 Carl Zeiss
15.5 Cytosmart
15.6 Danaher
15.7 Etaluma
15.8 GE Healthcare
15.9 Keyence
15.10 Logos Biosystems
15.11 Merck Kgaa
15.12 Nanoentek
15.13 Nanolive
15.14 Nikon
15.15 Perkinelmer
15.16 Phase Focus
15.17 Sartorius
15.18 Sony Biotechnology
15.19 Thermo Fisher Scientific
16 Appendix
16.1 Questionnaire

Companies Mentioned

  • Biotek Instruments
  • Becton, Dickinson & Company
  • Bruker
  • Carl Zeiss
  • Cytosmart
  • Danaher
  • Etaluma
  • GE Healthcare
  • Keyence
  • Logos Biosystems
  • Merck Kgaa
  • Nanoentek
  • Nanolive
  • Nikon
  • Perkinelmer
  • Phase Focus
  • Sartorius
  • Sony Biotechnology
  • Thermo Fisher Scientific